Market & Industry Briefs
Executive Summary
Brief summaries of recent medtech market and industry developments. This month we cover KCI's shift to private status, J&J's exit from drug-eluting stents, safety concerns about Edwards' Sapien TAVI device, and the MoneyTree 2Q2011 report on medtech venture financings.
You may also be interested in...
Medical Device Market & Industry Briefs, May 2012
Brief summaries of recent medtech market and industry developments. This month we cover Hologic’s acquisition of Gen-Probe, highlights from Heart Rhythm 2012 and a wrap-up of life sciences venture capital funding for Q1 2012.
Fractional Flow Reserve Makes Inroads In Interventional Cardiology
Fractional flow reserve (FFR), a measurement of the severity of a coronary artery obstruction, has not yet reached mainstream use in the US, but that could soon change as interventional cardiologists face increased scrutiny about the “appropriateness” of their clinical treatment decisions. Part of that scrutiny will be driven by recent overstenting scandals, but cost-control measures are playing just much of a role in this shift. At the same time, ongoing advancements in FFR technology are helping to overcome barriers to use and could convince more physicians and hospitals to jump on the FFR bandwagon.
As TAVI Advances, Adjunctive Devices Multiply
As researchers work to more fully understand the risks and durability of transcatheter aortic heart valve implantation (TAVI) procedures, device innovators are already attempting to engineer solutions to some of the more obvious areas of unmet need.